ASTRAZENECA PLC (AZN)
Clinical trial NCT04417062 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. enrollment: 63 → 49 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04417062 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. enrollment: 63 → 49 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Low confidence analysis (52%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical